Newborn Metabolic Screening: The Heel Stick That Saves Lives—and What to Do When It's Abnormal

 

Newborn Metabolic Screening: The Heel Stick That Saves Lives—and What to Do When It's Abnormal

RUSP conditions, premature infant false positives, the second screen, and the results that can't wait.

The newborn screening (NBS) panel is one of the most successful public health programs in history. A few drops of blood from a heel stick, collected 24–48 hours after birth, screen for dozens of conditions where early detection and treatment prevent death or irreversible disability. Yet many NPs don't know what's on the panel, what an abnormal result means, or how urgently to act.

What's Screened: The RUSP Core Conditions

The Recommended Uniform Screening Panel (RUSP) includes 37 core conditions and 26 secondary conditions. Every state screens for the core conditions, though the exact panel varies slightly by state. The critical time-sensitive conditions include:

Condition	Why It's Urgent	What Happens If Missed
Congenital hypothyroidism	Thyroid hormone essential for brain development	Irreversible intellectual disability ("cretinism") if untreated by 2–4 weeks
PKU (Phenylketonuria)	Cannot metabolize phenylalanine	Severe intellectual disability without dietary restriction
Galactosemia	Cannot metabolize galactose (in breast milk/formula)	E. coli sepsis, liver failure, death in first weeks
CAH (Congenital Adrenal Hyperplasia)	21-hydroxylase deficiency; salt-wasting crisis	Adrenal crisis, hyponatremia, hyperkalemia, shock, death by 2–3 weeks (salt-wasting form)
Sickle Cell Disease	Early penicillin prophylaxis prevents pneumococcal sepsis	Overwhelming sepsis and death in infancy without prophylaxis
CF (Cystic Fibrosis)	Early treatment improves pulmonary and nutritional outcomes	Failure to thrive, recurrent pneumonia, bronchiectasis
SCID (Severe Combined Immunodeficiency)	Added to RUSP in 2010 (TREC assay); pre-transplant management	Fatal infections by 1–2 years without bone marrow transplant
CCHD (Critical Congenital Heart Disease)	Pulse oximetry screening (not bloodwork); detect ductal-dependent lesions	Cardiovascular collapse when ductus closes

Additional core conditions include: medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, maple syrup urine disease, biotinidase deficiency, homocystinuria, congenital toxoplasmosis (some states), hearing loss (audiologic screen), and various organic acidemias and fatty acid oxidation disorders.

Timing and Collection

• First screen: 24–48 hours after birth (after adequate protein feeding to detect amino acid disorders). Screens collected before 24 hours have higher false-negative rates for some conditions.
• Second screen: Many states require a repeat at 1–2 weeks of age. This catches conditions that were falsely negative on the first screen (especially congenital hypothyroidism and CAH).
• Premature infants: The initial screen should still be collected, but a repeat is essential at 2 weeks or at discharge, whichever comes first. Premature infants have higher rates of false-positive AND false-negative results due to immature enzyme systems and transfusions.

When Time Is Critical

An abnormal NBS result for galactosemia, MSUD (maple syrup urine disease), or CAH salt-wasting form requires action within HOURS to DAYS. These are metabolic emergencies. When the state lab calls with a critical NBS result, treat it as urgently as a critical lab value in the ED. Refer immediately to the pediatric metabolic or endocrine specialist. Do not wait for confirmatory testing to initiate management for galactosemia (switch to soy formula immediately) or CAH (start hydrocortisone and fludrocortisone).

What to Do With an Abnormal Screen

1. Don't panic the family, but don't delay. An abnormal screen is not a diagnosis—it's a flag that requires confirmatory testing. But some conditions (above) can't wait.
2. Contact the state NBS follow-up program immediately for guidance on which specialist to involve and what confirmatory tests to order.
3. Confirmatory testing varies by condition: thyroid panel for congenital hypothyroidism, hemoglobin electrophoresis for sickle cell, sweat chloride test for CF, plasma amino acids for PKU/MSUD, 17-hydroxyprogesterone for CAH, TREC assay repeat + lymphocyte subsets for SCID.
4. Document and track. The most dangerous NBS failure is the abnormal result that gets lost in the system—the family was discharged, the result arrived at the hospital after discharge, and nobody followed up.

The #1 System Failure

The most common reason newborn screening fails to prevent disability is loss to follow-up—the result comes back abnormal but nobody contacts the family. If you see a newborn in primary care at the 2-week or 1-month visit, always verify that NBS results have been received and reviewed. If results aren't in the chart, track them down before the visit ends.

The Pitfalls

• False positives are common, especially in preterm infants. An abnormal screen is not a diagnosis. But it always requires follow-up.
• False negatives happen: congenital hypothyroidism can be missed on the first screen if the TSH hasn't risen yet (especially in central hypothyroidism, which NBS doesn't detect in most states). The second screen catches many of these.
• Transfused infants: Blood transfusions before NBS can cause false-negative results for hemoglobinopathies (the donor's normal hemoglobin masks the baby's abnormal hemoglobin). Repeat hemoglobin electrophoresis at 3–4 months in transfused infants.
• Carrier status detection: NBS may identify sickle cell trait (FAS pattern) or CF carrier status. These require genetic counseling but NOT treatment. Communicate clearly to families that carrier status is not disease.
• Home births and early discharges: Infants born at home or discharged before 24 hours are at higher risk for missed or improperly timed screens. Always verify screening status at the first primary care visit.

Bottom Line

Newborn screening is a time-sensitive public health program that prevents death and disability—but only if the results are received, reviewed, and acted on. Know which conditions require emergent action (galactosemia, CAH, MSUD). Know that an abnormal screen is a flag, not a diagnosis. Always verify NBS completion at the first primary care visit. And never let an abnormal result get lost in the system.

Stay sharp out there.